|
OGEN | Oragenics Inc |
|
|
OGEN | Oragenics Inc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 3.15 |
| Leverage | 40.86% |
| Market Cap | $ 976.4k |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -19.7m |
| Margin | 267932.24% |
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.